OptimizeRx Corporation (OPRX)
NASDAQ: OPRX · Real-Time Price · USD
12.53
-0.09 (-0.71%)
At close: Aug 1, 2025, 4:00 PM
12.43
-0.10 (-0.80%)
After-hours: Aug 1, 2025, 7:54 PM EDT

Company Description

OptimizeRx Corporation operates as a digital healthcare technology company.

The company offers Dynamic Audience Activation Platform, which generates dynamic audiences with predictive analytics through machine learning methods; Micro-Neighborhood Targeting, which creates consumer audiences using a privacy-first process; Profiler, which provides insights into its customers’ target consumers; banner messages, including brand messaging, therapeutic support messaging, affordability messaging, HUB awareness, limited distribution drug information, and patient support program messaging through healthcare professionals; and media execution solutions, which deliver messages through consumer omnichannel network, including through programmatic display, programmatic connected television/over-the-top, programmatic social media, addressable television, digital out-of-home, programmatic audio, and email/direct mail.

It also offers pharmacy alerts, which flag pharmacies that have prescription medications in stock; and financial messaging solutions, which provide prescribers visibility to branded copay offers for patients directly within electronic health record systems and ePrescribing platforms.

The company was founded in 2006 and is based in Waltham, Massachusetts.

OptimizeRx Corporation
OptimizeRx logo
CountryUnited States
Founded2006
IndustryHealth Information Services
SectorHealthcare
Employees129
CEOStephen Silvestro

Contact Details

Address:
260 Charles Street, Suite 302
Waltham, Massachusetts 02453
United States
Phone248 651 6568
Websiteoptimizerx.com

Stock Details

Ticker SymbolOPRX
ExchangeNASDAQ
Fiscal YearJanuary - December
Reporting CurrencyUSD
CIK Code0001448431
CUSIP Number68401U204
ISIN NumberUS68401U2042
Employer ID26-1265381
SIC Code7389

Key Executives

NamePosition
Stephen L. SilvestroPresident and Chief Executive Officer
Edward Stelmakh C.M.A., M.B.A.Chief Financial Officer and Chief Operating Officer
Andrew Jacob D'SilvaSenior Vice President of Corporate Finance
Marion K Odence-FordChief Legal Officer and Chief Human Resources Officer
Maira AlejandraMedia Relations Manager
Dr. Doug BeschChief Product Officer and Chief Technology Officer
Theresa GrecoChief Commercial Officer
Heather FavazzaController
Sheryl KearneyHuman Resources Manager

Latest SEC Filings

DateTypeTitle
Jul 16, 2025SCHEDULE 13G/AFiling
Jun 24, 20258-KCurrent Report
Jun 16, 20258-KCurrent Report
May 13, 202510-QQuarterly Report
May 12, 20258-KCurrent Report
Apr 30, 2025SCHEDULE 13G/AFiling
Apr 30, 2025ARSFiling
Apr 30, 2025DEF 14AOther definitive proxy statements
Apr 21, 2025SCHEDULE 13D/AFiling
Apr 18, 20258-KCurrent Report